WS #15762
UnitedHealth Group reported Q3 adjusted EPS of $4.69, beating estimates by 13.3%, and raised its full-year adjusted EPS outlook to at least $20.50. The company highlighted a medical cost ratio of 88.4%, significantly better than the 90.1% estimate, demonstrating effective cost management despite high healthcare utilization. This earnings beat reinforces the resilience of large-cap healthcare insurers and provides a positive anchor for the sector amidst broader market volatility.
UnitedHealth Earnings Beat
UnitedHealth Group reported Q3 adjusted EPS of $4.69, beating estimates by 13.3%, and raised its full-year adjusted EPS outlook to at least $20.50. The company highlighted a medical cost ratio of 88.4%, significantly better than the 90.1% estimate, demonstrating effective cost management despite high healthcare utilization. This earnings beat reinforces the resilience of large-cap healthcare insurers and provides a positive anchor for the sector amidst broader market volatility.